Lini Imaji Kreasi Ekosistem Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Lini Imaji Kreasi Ekosistem Tbk. trades at Rp226 (market cap 1.49T, 28.32M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 7.5× Lini Imaji Kreasi Ekosistem Tbk.'s market cap, and Lini Imaji Kreasi Ekosistem Tbk. is more actively traded (28.32M versus 613K). Which is the better fit depends on your goals.
| FUTR | TSPC | |
|---|---|---|
Market Cap | 1.49T | 11.18T |
Volume | 28.32M | 613K |
Lot | 283.22K | 6.13K |
Turnover | 6.41B | 1.54B |
Average Price | 226.29 | 2,511.52 |
Value | 6.41B | 1.54B |
Indicative Equilibrium Price | 226 | 2,520 |
Indicative Equilibrium Volume | 4.51K | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lini Imaji Kreasi Ekosistem Tbk (the “Company”) was established under the name of PT LinikiniAspirasi Kreasi based on Notarial Deed No. 74 of Janty Lega, S.H., M.Kn., dated July 29, 2021. The Company started its commercial operations in 2021. The immediate and ultimate parent entities of the Company are PT Digital Futurama Global and PT Investasi Gemilang Maju, respectively.
Read more on FUTR →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →